CAR-T

Businessman about to be crushed by falling dominos

Fierce Pharma

BioNTech to wind down cell therapy manufacturing in Maryland

After a poor performance from its CAR-T candidate in a phase 1 cancer trial, BioNTech is ending cell therapy manufacturing at its first U.S. plant.

Fraiser Kansteiner Jun 18, 2025 10:23am

Graphic of a drop of blood made up of small data points and nodes

J&J lymphoma CAR-T hits 100% ORR in 10 patients

Jun 13, 2025 1:22pm

rainbow kite flying in the sky

ASCO: Kite's CAR-T flies high in phase 1 B-cell lymphoma study

May 31, 2025 7:00pm

Lifeline

HCW Biologics clings on with $5M lifeline to fund alopecia trial

May 16, 2025 7:00am

A series of dice with a bag on them illustrating cost cuts

Allogene lays off 28% of staff to save cash amid program delays

May 14, 2025 8:00am

layoffs cuts workforce reduction chairs boxes fired

Kyverna lays off 16% as autoimmune CAR-T plans take shape

May 14, 2025 6:30am